Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Life Sciences
|
February 6, 2021
BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats
Sameh Saber, Mahmoud E Youssef, Hossam Sharaf, et al.
Journal of Inflammation Research
|
July 29, 2021
The Supportive Role of NSC328382, a P2X7R Antagonist, in Enhancing the Inhibitory Effect of CRID3 on NLRP3 Inflammasome Activation in Rats with Dextran Sodium Sulfate-Induced Colitis
Sameh Saber, Galal Yahya, Naglaa A Gobba, et al.
Life Sciences
|
October 24, 2021
Blunting p38 MAPKα and ERK1/2 activities by empagliflozin enhances the antifibrotic effect of metformin and augments its AMPK-induced NF-κB inactivation in mice intoxicated with carbon tetrachloride
Amir Mohamed Abdelhamid, Mahmoud E Youssef, Eslam E Abd El-Fattah, et al.
Frontiers in Pharmacology
|
October 3, 2024
Activation of AMPK/SIRT1/FOXO3a signaling by BMS-477118 (saxagliptin) mitigates chronic colitis in rats: uncovering new anti-inflammatory and antifibrotic roles
Elsayed A Elmorsy, Mahmoud E Youssef, Mohamed R Abdel-Hamed, et al.
Inflammopharmacology
|
December 17, 2025
Natural products as HMG-CoA reductase inhibitors (statins) for the management of non-communicable diseases
Radwa N Muhammad, Nora M Aborehab, Shaza H Aly, et al.
Frontiers in Pharmacology
|
January 31, 2022
AKT-AMPKα-mTOR-dependent HIF-1α Activation is a New Therapeutic Target for Cancer Treatment: A Novel Approach to Repositioning the Antidiabetic Drug Sitagliptin for the Management of Hepatocellular Carcinoma
Eslam E Abd El-Fattah, Sameh Saber, Mahmoud E Youssef, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 4, 2025
A Systems Biology Perspective on Childhood ADHD: Neurochemical Dysregulation, Brain-Behavior Interactions, and Emerging Therapeutics
Norah Suliman Alsoqih, Elsayed A Elmorsy, Rasha Abu-Khudir, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
February 24, 2022
Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-κB and NLRP3 crosstalk: A novel approach for filling an unmet medical need
Mona H Zohny, Simona Cavalu, Mahmoud E Youssef, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 9, 2022
Pimitespib, an HSP90 inhibitor, augments nifuroxazide-induced disruption in the IL-6/STAT3/HIF-1α autocrine loop in rats with bleomycin-challenged lungs: Evolutionary perspective in managing pulmonary fibrosis
Dalia H El-Kashef, Mahmoud E Youssef, Mohamed Nasr, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 29, 2021
Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application
Amir Mohamed Abdelhamid, Sameh Saber, Mahmoud E Youssef, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Life Sciences
|
February 6, 2021
BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats
Sameh Saber, Mahmoud E Youssef, Hossam Sharaf, et al.
Journal of Inflammation Research
|
July 29, 2021
The Supportive Role of NSC328382, a P2X7R Antagonist, in Enhancing the Inhibitory Effect of CRID3 on NLRP3 Inflammasome Activation in Rats with Dextran Sodium Sulfate-Induced Colitis
Sameh Saber, Galal Yahya, Naglaa A Gobba, et al.
Life Sciences
|
October 24, 2021
Blunting p38 MAPKα and ERK1/2 activities by empagliflozin enhances the antifibrotic effect of metformin and augments its AMPK-induced NF-κB inactivation in mice intoxicated with carbon tetrachloride
Amir Mohamed Abdelhamid, Mahmoud E Youssef, Eslam E Abd El-Fattah, et al.
Frontiers in Pharmacology
|
October 3, 2024
Activation of AMPK/SIRT1/FOXO3a signaling by BMS-477118 (saxagliptin) mitigates chronic colitis in rats: uncovering new anti-inflammatory and antifibrotic roles
Elsayed A Elmorsy, Mahmoud E Youssef, Mohamed R Abdel-Hamed, et al.
Inflammopharmacology
|
December 17, 2025
Natural products as HMG-CoA reductase inhibitors (statins) for the management of non-communicable diseases
Radwa N Muhammad, Nora M Aborehab, Shaza H Aly, et al.
Frontiers in Pharmacology
|
January 31, 2022
AKT-AMPKα-mTOR-dependent HIF-1α Activation is a New Therapeutic Target for Cancer Treatment: A Novel Approach to Repositioning the Antidiabetic Drug Sitagliptin for the Management of Hepatocellular Carcinoma
Eslam E Abd El-Fattah, Sameh Saber, Mahmoud E Youssef, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 4, 2025
A Systems Biology Perspective on Childhood ADHD: Neurochemical Dysregulation, Brain-Behavior Interactions, and Emerging Therapeutics
Norah Suliman Alsoqih, Elsayed A Elmorsy, Rasha Abu-Khudir, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
February 24, 2022
Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-κB and NLRP3 crosstalk: A novel approach for filling an unmet medical need
Mona H Zohny, Simona Cavalu, Mahmoud E Youssef, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 9, 2022
Pimitespib, an HSP90 inhibitor, augments nifuroxazide-induced disruption in the IL-6/STAT3/HIF-1α autocrine loop in rats with bleomycin-challenged lungs: Evolutionary perspective in managing pulmonary fibrosis
Dalia H El-Kashef, Mahmoud E Youssef, Mohamed Nasr, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 29, 2021
Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application
Amir Mohamed Abdelhamid, Sameh Saber, Mahmoud E Youssef, et al.
Page
of 10